Topical hemostatic agents and dressings in the prehospital setting

Current Opinion in Anaesthesiology

Volumn 28, Issue 2, 2015, Pages 210-216

  Grissom, Thomas E ^a   Fang, Raymond ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

Author keywords

chitosan; emergency medical services; hemorrhage; hemostatics; military medicine

Indexed keywords

CHITOSAN; HEMOSTATIC AGENT; PROCOAGULANT; BLOOD CLOTTING FACTOR;

ARMY; DISEASE CLASSIFICATION; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EXSANGUINATION; GAUZE DRESSING; HUMAN; LABORATORY; MILITARY MEDICINE; PRIORITY JOURNAL; REVIEW; WOUND DRESSING; ANIMAL; BANDAGE; HEMORRHAGE; HEMOSTASIS; PROCEDURES;

ANIMALS; BANDAGES; BLOOD COAGULATION FACTORS; EMERGENCY MEDICAL SERVICES; HEMORRHAGE; HEMOSTASIS; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HUMANS;

EID: 84926318644     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000166     Document Type: Review

References (64)

1. Eastridge BJ, Mabry RL, Seguin P, et al. Death on the battlefield (2001-2011): implications for the future of combat casualty care. J Trauma Acute Care Surg 2012; 73: S431-S437.
2. Teixeira PG, Inaba K, Hadjizacharia P, et al. Preventable or potentially preventable mortality at a mature trauma center. J Trauma 2007; 63: 1338-1346.
3. Kragh JF Jr, Littrel ML, Jones JA, et al. Battle casualty survival with emergency tourniquet use to stop limb bleeding. J Emerg Med 2011; 41: 590-597.
4. Bennett BL, Littlejohn LF, Kheirabadi BS, et al. Management of external hemorrhage in tactical combat casualty care: chitosan-based hemostatic gauze dressings -TCCC Guidelines-Change 13-05. J Spec Oper Med 2014; 14: 40-57.
5. Bulger EM, Snyder D, Schoelles K, et al. An evidence-based prehospital guideline for external hemorrhage control: American College of Surgeons Committee on Trauma. Prehosp Emerg Care 2014; 18: 163-173.
6. Shander A, Kaplan LJ, Harris MT, et al. Topical hemostatic therapy in surgery: bridging the knowledge and practice gap. J Am Coll Surg 2014; 219: 570-579.
7. Achneck HE, Sileshi B, Jamiolkowski RM, et al. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010; 251: 217-228.
8. Gabay M, Boucher BA. An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis. Pharmacotherapy 2013; 33: 935-955.
9. Shanmugam V, Robinson MH. Case report of uncontrollable pelvic bleeding-managed by a previously unreportedmethod (QuikClot). Colorectal Dis 2009; 11: 221-222.
10. Schmid BC, Rezniczek GA, Rolf N, Maul H. Postpartum hemorrhage: use of hemostatic Combat Gauze. Am J Obstet Gynecol 2012; 206: e12-e13.
11. Millner RW, Lockhart AS, Bird H, Alexiou C. A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery. Ann Thorac Surg 2009; 87: e13-e14.
12. Muzzi L, Tommasino G, Tucci E, Neri E. Successful use of a military haemostatic agent in patients undergoing extracorporeal circulatory assistance and delayed sternal closure. Interact Cardiovasc Thorac Surg 2012; 14: 695-698.
13. King DR, Schreiber MA. The mRDH bandage provides effective hemostasis in trauma and surgical hemorrhage. J Trauma 2011; 71: S167-S170.
14. King DR. Thirty consecutive uses of a hemostatic bandage at a US Army combat support hospital and forward surgical team in Operation Iraqi Freedom. J Trauma 2011; 71: 1775-1778.
15. Salerno TA, Gaughan C, Suarez M, Panos AL. Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). J Card Surg 2009; 24: 722-724.
16. Kheirabadi B. Evaluation of topical hemostatic agents for combat wound treatment. US Army Med Dep J 2011; 25-37.
17. Granville-Chapman J, Jacobs N, Midwinter MJ. Prehospital haemostatic dressings: a systematic review. Injury 2011; 42: 447-459.
18. Bennett BL, Littlejohn L. Review of new topical hemostatic dressings for combat casualty care. Mil Med 2014; 179: 497-514.
19. Smith AH, Laird C, Porter K, Bloch M. Haemostatic dressings in prehospital care. Emerg Med J 2013; 30: 784-789.
20. Kheirabadi BS, Arnaud F, McCarron R, et al. Development of a standard swine hemorrhage model for efficacy assessment of topical hemostatic agents. J Trauma 2011; 71: S139-S146.
21. Rhee P, Brown C, Martin M, et al. QuikClot use in trauma for hemorrhage control: case series of 103 documented uses. J Trauma 2008; 64: 1093-1099.
22. Wedmore I, McManus JG, Pusateri AE, Holcomb JB. A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J Trauma 2006; 60: 655-658.
23. Brown MA, Daya MR, Worley JA. Experience with chitosan dressings in a civilian EMS system. J Emerg Med 2009; 37: 1-7.
24. Pozza M, Millner RW. Celox (chitosan) for haemostasis in massive traumatic bleeding: experience in Afghanistan. Eur J Emerg Med 2011; 18: 31-33.
25. Kotwal RS, Montgomery HR, Kotwal BM, et al. Eliminating preventable death on the battlefield. Arch Surg 2011; 146: 1350-1358.
26. Tan ECTH, Bleeker CP. Field experience with chitosan-based haemostatic dressing. Med Corps Int Forum 2011; 3: 11-14.
27. Arul GS, Bowley DM, DiRusso S. The use of Celox gauze as an adjunct to pelvic packing in otherwise uncontrollable pelvic haemorrhage secondary to penetrating trauma. J R Army Med Corps 2012; 158: 331-333.
28. Ran Y, Hadad E, Daher S, et al. QuikClot Combat Gauze use for hemorrhage control inmilitary trauma: January 2009 Israel Defense Force experience in the Gaza Strip -a preliminary report of 14 cases. Prehosp Disaster Med 2010; 25: 584-588.
29. Lairet JR, Bebarta VS, Burns CJ, et al. Prehospital interventions performed in a combat zone: a prospective multicenter study of 1, 003 combat wounded. J Trauma Acute Care Surg 2012; 73: S38-S42.
30. Cox ED, Schreiber MA, McManus J, et al. New hemostatic agents in the combat setting. Transfusion 2009; 49 (Suppl 5): 248S-255S.
31. Kheirabadi BS, Scherer MR, Estep JS, et al. Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine. J Trauma 2009; 67: 450-459.
32. Arnaud F, Parreno-Sadalan D, Tomori T, et al. Comparison of 10 hemostatic dressings in a groin transection model in swine. J Trauma 2009; 67: 848-855.
33. Gegel BT, Austin PN, Johnson AD. An evidence-based review of the use of a Combat Gauze (QuikClot) for hemorrhage control. AANA J 2013; 81: 453-458.
34. Sorensen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 2012; 99 (Suppl 1): 40-50.
35. Floyd CT, Rothwell SW, Risdahl J, et al. Salmon thrombin-fibrinogen dressing allows greater survival and preserves distal blood flow compared to standard kaolin gauze in coagulopathic swine with a standardized lethal femoral artery injury. J Spec Oper Med 2012; 12: 16-26.
36. Kheirabadi BS, Mace JE, Terrazas IB, et al. Clot-inducing minerals versus plasma protein dressing for topical treatment of external bleeding in the presence of coagulopathy. J Trauma 2010; 69: 1062-1072.
37. Causey MW, McVay DP, Miller S, et al. The efficacy of Combat Gauze in extreme physiologic conditions. J Surg Res 2012; 177: 301-305.
38. Sena MJ, Douglas G, Gerlach T, et al. A pilot study of the use of kaolinimpregnated gauze (CombatGauze) for packing high-grade hepatic injuries in a hypothermic coagulopathic swine model. J Surg Res 2013; 183: 704-709.
39. Rall JM, Cox JM, Songer AG, et al. Comparison of novel hemostatic dressings with QuikClot Combat Gauze in a standardized swine model of uncontrolled hemorrhage. J Trauma Acute Care Surg 2013; 75: S150-S156.
40. Floyd CT, Rothwell SW, Martin R, et al. A salmon thrombin-fibrinogen dressing controls hemorrhage in a swine model compared to standard kaolin-coated gauze. J Spec Oper Med 2012; 12: 49-55.
41. Arnaud F, Tomori T, Carr W, et al. Exothermic reaction in zeolite hemostatic dressings: QuikClotACSandACS+. Ann Biomed Eng2008; 36: 1708-1713.
42. Lewis KM, Atlee H, Mannone A, et al. Efficacy of hemostatic matrix and microporous polysaccharide hemospheres. J Surg Res 2015; 193: 825-830.
43. Gegel BT, Burgert JM, Lockhart C, et al. Effects of Celox and TraumaDEX on hemorrhage control in a porcine model. AANA J 2010; 78: 115-120.
44. Alam HB, Uy GB, Miller D, et al. Comparative analysis of hemostatic agents in a swine model of lethal groin injury. J Trauma 2003; 54: 1077-1082.
45. Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol 2010; 56: 290-299.
46. Aranaz I, Mengibar M, Harris R, et al. Functional characterization of chitin and chitosan. Curr Chem Biol 2009; 3: 203-230.
47. Chou TC, Fu E, Wu CJ, Yeh JH. Chitosan enhances platelet adhesion and aggregation. Biochem Biophys Res Commun 2003; 302: 480-483.
48. Millner R, Lockhart AS, Marr R. Chitosan arrests bleeding in major hepatic injuries with clotting dysfunction: an in vivo experimental study in a model of hepatic injury in the presence of moderate systemic heparinisation. Ann R Coll Surg Engl 2010; 92: 559-561.
49. Koksal O, Ozdemir F, Cam Etoz B, et al. Hemostatic effect of a chitosan linear polymer (Celox(R)) in a severe femoral artery bleeding rat model under hypothermia or warfarin therapy. Ulus Travma Acil Cerrahi Derg 2011; 17: 199-204.
50. Pusateri AE, McCarthy SJ, Gregory KW, et al. Effect of a chitosanbased hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma 2003; 54: 177-182.
51. Arnaud F, Teranishi K, Tomori T, et al. Comparison of 10 hemostatic dressings in a groin puncture model in swine. J Vasc Surg 2009; 50: 632-639.
52. Devlin JJ, Kircher S, Kozen BG, et al. Comparison of ChitoFlex(R), CELOX, and QuikClot(R) in control of hemorrhage. J Emerg Med 2011; 41: 237-245.
53. Littlejohn LF, Devlin JJ, Kircher SS, et al. Comparison of Celox-A, ChitoFlex, WoundStat, and Combat Gauze hemostatic agents versus standard gauze dressing in control of hemorrhage in a swine model of penetrating trauma. Acad Emerg Med 2011; 18: 340-350.
54. Schwartz RB, Reynolds BZ, Shiver SA, et al. Comparison of two packable hemostatic Gauze dressings in a porcine hemorrhage model. Prehosp Emerg Care 2011; 15: 477-482.
55. Kheirabadi BS, Edens JW, Terrazas IB, et al. Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine. J Trauma 2009; 66: 316-326.
56. Sohn VY, Eckert MJ, Martin MJ, et al. Efficacy of three topical hemostatic agents applied by medics in a lethal groin injury model. J Surg Res 2009; 154: 258-261.
57. Schmid BC, Rezniczek GA, Rolf N, et al. Uterine packing with chitosancovered gauze for control of postpartum hemorrhage. Am J Obstet Gynecol 2013; 209: 225.e1-225.e5.
58. Valeri CR, Vournakis JN. mRDH bandage for surgery and trauma: data summary and comparative review. J Trauma 2011; 71: S162-S166.
59. Satterly S, Nelson D, Zwintscher N, et al. Hemostasis in a noncompressible hemorrhage model: an end-user evaluation of hemostatic agents in a proximal arterial injury. J Surg Educ 2013; 70: 206-211.
60. Kunio NR, Riha GM, Watson KM, et al. Chitosan based advanced hemostatic dressing is associated with decreased blood loss in a swine uncontrolled hemorrhage model. Am J Surg 2013; 205: 505-510.
61. Rago AP, Duggan MJ, Beagle J, et al. Self-expanding foam for prehospital treatment of intra-abdominal hemorrhage: 28-day survival and safety. J Trauma Acute Care Surg 2014; 77: S127-S133.
62. Rago A, Duggan MJ, Marini J, et al. Self-expanding foam improves survival following a lethal, exsanguinating iliac artery injury. J Trauma Acute Care Surg 2014; 77: 73-77.
63. Dowling MB, Smith W, Balogh P, et al. Hydrophobically-modified chitosan foam: description and hemostatic efficacy. J Surg Res 2014; 193: 316-323.
64. Behrens AM, Sikorski MJ, Li T, et al. Blood-aggregating hydrogel particles for use as a hemostatic agent. Acta Biomater 2014; 10: 701-708.